Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 10/31/2025 | 07/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 188.17% | 69.07% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 188.17% | 69.07% | |||
| Cost of Revenue | 148.58% | 1.81% | |||
| Gross Profit | 205.86% | 139.92% | |||
| SG&A Expenses | 105.50% | -14.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 114.58% | -11.46% | |||
| Operating Income | 43.87% | 56.29% | |||
| Income Before Tax | -31.59% | 61.87% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -31.59% | 61.87% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -31.59% | 61.87% | |||
| EBIT | 43.87% | 56.29% | |||
| EBITDA | 43.87% | 56.29% | |||
| EPS Basic | -33.33% | 62.50% | |||
| Normalized Basic EPS | -25.00% | 60.00% | |||
| EPS Diluted | -33.33% | 62.50% | |||
| Normalized Diluted EPS | -25.00% | 60.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||